AR and posterior cortical atrophy: These compounds demonstrated marked anti-AR potency against both full-length and the constitutively active splice variant AR-V7, and the lead compound VPC-14449 effectively suppressed cell viability and AR transcriptional activity in various PCa cell models [49,50].